Syndax Pharmaceuticals, Inc.
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Public
- Established
- 2005-01-01
- Employees
- 184
- Market Cap
- -
- Website
- http://www.syndax.com
Clinical Trials
17
Active:13
Completed:1
Trial Phases
2 Phases
Phase 1:15
Phase 2:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (16 trials with phase data)• Click on a phase to view related trials
Phase 1
15 (93.8%)Phase 2
1 (6.3%)No trials found
News
Syndax's Revumenib Shows Positive Phase II Results in AML
Syndax Pharmaceuticals announced positive top-line results from the pivotal Phase II portion of the Augment-101 study, evaluating revumenib in acute myeloid leukemia (AML).